Join to View Full Profile
100 White Spruce BlvdSuite 3Rochester, NY 14623
Phone+1 585-272-0700
Fax+1 585-272-8356
Dr. Tu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Rochester Institute of OpticsMS, Optics, 2001 - 2003
Massachusetts General HospitalPost-Doctoral Fellowship, 1998 - 2000
Washington University/B-JH/SLCH ConsortiumResidency, Dermatology, 1995 - 1998
UCLA David Geffen School of Medicine/UCLA Medical CenterInternship, Internal Medicine, 1994 - 1995
Albert Einstein College of MedicineClass of 1994
Certifications & Licensure
NY State Medical License 2001 - 2026
American Board of Dermatology Dermatology
Awards, Honors, & Recognition
- Fellow (FAAD) American Academy of Dermatology
- Fellow (FASDS) American Society for Dermatologic Surgery
Clinical Trials
- VPD-737 for Treatment of Chronic Pruritus Start of enrollment: 2013 Oct 15
- Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Chronic Plaque Psoriasis (PsO) Start of enrollment: 2014 Jun 16
- A Study of Multiple Doses of AbGn-168H by Intravenous Infusion in Patients With Moderate to Severe Chronic Plaque Psoriasis Start of enrollment: 2014 May 01
- Join now to see all
Publications & Presentations
PubMed
- A Non-randomized, Open-label, Multicenter Study to Evaluate the Safety and Tolerability of 10% Aminolevulinic Acid Gel in the Expanded Field-directed Treatment of Acti...Joel L Cohen, John H Tu, Megan P Couvillion, S Sasha Jazayeri, Nathalie C Zeitouni
The Journal of Clinical and Aesthetic Dermatology. 2025-04-01 - 1 citationsEffect of NFX-179 MEK inhibitor on cutaneous neurofibromas in persons with neurofibromatosis type 1.Kavita Y Sarin, Mark Bradshaw, Chris O'Mara, Jahanbanoo Shahryari, John Kincaid
Science Advances. 2024-05-03 - 151 citationsEvidence that a neutrophil-keratinocyte crosstalk is an early target of IL-17A inhibition in psoriasis.Kristian Reich, Kim A. Papp, Robert Matheson, John H. Tu, Robert Bissonnette
Experimental Dermatology. 2015-07-01
Professional Memberships
- Fellow
- Fellow
Other Languages
- Chinese (Mandarin)
External Links
- Officehttps://www.dermrochester.com/
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
